ZR-75-1 GRB7 [ZR-GRB7 (3)] cell line

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

• Name: ZR-75-1 GRB7 [ZR-GRB7 (3)] cell line
• Alternate name: Growth Factor Receptor Bound Protein 7
• Cancer: Gynaecologic cancer
• Cancers detailed: Mammary ductal carcinoma
• Research fields: Cancer;Drug development
• Tool sub type: Continuous
• Parental cell: ZR-75-1
• Organism: Human
• Tissue: Breast
• Disease: Cancer
• Model: Cancer Model
• Description: Breast cancer is widely and effectively treated with endocrine treatment. However, in many cases the tumours will eventually progress into an estrogen-independent and therapy-resistant phenotype.Seven genes including AKT1, AKT2, BCAR1, BCAR2, BCAR3, EGFR2 and GRB7 have been shown to directly underlie estrogen independence in human breast cancer cells. This cell line is part of a panel of 16 cell lines (Cat No 154621-154635, 154642) which have been transfected with these genes, plus the parental (Cat No 154547).This cell line is a powerful tool for studying the molecular and cellular mechanisms of breast tumour progression, therapy resistance and to test the effectiveness of novel drugs to combat different modes of anti-estrogen insensitivity
• Production details: Expression constructs with GRB7 were transfected into ZR-75-1 cells using FuGENE 6 and selected with G418. After selection for G418 resistance colonies were expanded
• Biosafety level: 1

Target Details

• Target: GRB7

Applications

• Application notes: The cell line is resistant to Geneticin, which may be included in the culture medium to ensure that the expression vector is retained by the cells.

Handling

• Format: Frozen
• Growth medium: RPMI 1640 medium supplemented with 10% heat-inactivated bovine serum (RBCS) and 1 nM 17?-estradiol
• Unit size: 1x10^6 cells / vial
• Shipping conditions: Dry ice
• Storage conditions: Liquid Nitrogen
• Mycoplasma free: Yes

References

• van Agthoven et al. 2009. Breast Cancer Res Treat. 114(1):23-30. PMID: 18351453.